Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00006231
What this trial is testing

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaPerioperative/Postoperative Complications
University of Glasgow 44
Not applicableStudy completedNCT05404022
What this trial is testing

Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years

Who this might be right for
Lung Neoplasm MalignantMesothelioma; Lung
University of Hull 11
Testing effectiveness (Phase 2)Study completedNCT05005429
What this trial is testing

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma; Lung
Fundación GECP 47
Not applicableEnded earlyNCT02613299
What this trial is testing

Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

Who this might be right for
MesotheliomaSolitary Fibrous Tumor of the Pleura
Mayo Clinic 5
Testing effectiveness (Phase 2)Study completedNCT07411144
What this trial is testing

Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma

Who this might be right for
Diffuse Pleural Mesothelioma (DPM)
National Cancer Institute, Egypt 64
Testing effectiveness (Phase 2)Study completedNCT01160458
What this trial is testing

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
National Cancer Institute (NCI) 20
Not applicableEnded earlyNCT02672033
What this trial is testing

Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Pleural Epithelioid MesotheliomaPleural Malignant Mesothelioma
Jonsson Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Temporarily pausedNCT05337735
What this trial is testing

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Who this might be right for
Microsatellite High CancersPeritoneal MesotheliomaExtrapulmonary High Grade+5 more
M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)Ended earlyNCT05275478
What this trial is testing

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 110
Testing effectiveness (Phase 2)Ended earlyNCT00003508
What this trial is testing

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Who this might be right for
Malignant Mesothelioma
Burzynski Research Institute 8
Testing effectiveness (Phase 2)Looking for participantsNCT04515836
What this trial is testing

Olaparib in Patients With HRD Malignant Mesothelioma

Who this might be right for
MesotheliomaHomologous Recombination Deficiency
University of Chicago 56
Testing effectiveness (Phase 2)Study completedNCT04115111
What this trial is testing

Diadem to Investigate the Activity and Safety of Durvalumab

Who this might be right for
Pleura Mesothelioma
Mario Negri Institute for Pharmacological Research 57
Testing effectiveness (Phase 2)WithdrawnNCT03786419
What this trial is testing

Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma, AdvancedMalignant Pleural Mesothelioma, Unresectable
Health Pharma Professional Research
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)Looking for participantsNCT07121374
What this trial is testing

NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study

Who this might be right for
Pleural Epithelioid MesotheliomaMesothelioma; PleuraNeoadjuvant Chemoimmunotherapy
University Hospital, Antwerp 37
Testing effectiveness (Phase 2)Study completedNCT02460224
What this trial is testing

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 490
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Early research (Phase 1)Study completedNCT02639091
What this trial is testing

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Who this might be right for
Medical Oncology
Bayer 36
Early research (Phase 1)Ended earlyNCT02029690
What this trial is testing

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Pleural Mesothelioma Malignant AdvancedPeritoneal Mesothelioma Malignant AdvancedNon-squamous Non-small Cell Lung Carcinoma+4 more
Polaris Group 85
Next Page